Pfizer said it
would buy Botox maker Allergan in a record-breaking deal worth
$160 billion to cut its U.S. tax bill by moving its headquarters
to Ireland.
"The Pfizer-Allergan merger would be a disaster for American
consumers who already pay the highest prices in the world for
prescription drugs," Sanders said in a statement.
(Reporting by Doina Chiacu; Editing by Bill Trott)
[© 2015 Thomson Reuters. All rights
reserved.] Copyright 2015 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|